PF program HCPT treatment of malignant pleural effusion.doc

 PAGE \* MERGEFORMAT 12 PF program HCPT treatment of malignant pleural effusion 【Abstract】 Objective To use the 5-FU, DDP join the HCPT intrapleural malignant pleural effusion. Observation of efficacy and quality of life. February 2002 ~ March 2004 5-FU DDP HCPT three-drug combination treatment of malignant pleural effusion, with complete clinical data for 16 cases. Results The total effective rate 93.75%. Conclusions Treatment of malignant pleural effusion, three-drug combination of intrapleural injection, toxicity, good curative effect. Keywords: 5-FU DDP HCPT chemotherapy for malignant pleural effusion in the chest The past 10 years, at home and abroad on the treatment of malignant pleural effusion reported increased each day, in different ways, vary in efficacy, it is difficult to form a unified specification model. In this paper, in February 1998 ~ March 2001 lung cancer, 135 cases of hospitalized patients, including lung cancer and pleural effusion in 16 cases, accounting for 11.85%, with PF HCPT Intrapleural treatment program to achieve more satisfactory results, efficiency 93.75%. These are as follows. 1 Data and methods 1.1 General Information The group of 16 cases, 9 males and 7 females, aged 42 to 60 years old, with a median age of 46 years. Were characterized by X-ray, B Chao, CT, cytology or histological examination confirmed the diagnosis. Of which 9 cases of adenocarcinoma, squamous cell carcinoma, 5 cases of small cell carcinoma in 2 cases. The right side in 10 cases, left in 6 cases. 1.2 Treatment Pumping liquid discharge, 16 patients were ranked using fine-needle aspiration fluid. Armchair seat, under local anesthesia in order to locate the center of B-piercing the chest cavity, infusion tube pumping fluid. Extract of the number of patient effort can be tolerated as much as possible multi-slice pleural effusion. 1.2.1 Drug Administra